Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (68)

2024

  1. Concomitant treatment with safinamide and antidepressant drugs: Safety data from real clinical practice

    Neurologia, Vol. 39, Núm. 4, pp. 340-344

  2. Revisiting the jumping to conclusions bias in functional movement disorders

    Journal of Neurology, Neurosurgery and Psychiatry

2023

  1. Clinical Features of Idiopathic Normal Pressure Hydrocephalus: Critical Review of Objective Findings

    Movement Disorders Clinical Practice, Vol. 10, Núm. 1, pp. 9-16

  2. Cognitive impairment and dementia in young onset Parkinson’s disease

    Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812

  3. Functional movement disorder comorbidity in Parkinson's disease: A multicenter descriptive study

    Parkinsonism and Related Disorders

  4. Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: A national multicentre observational study

    Journal of Neurology, Neurosurgery and Psychiatry

  5. Switching from Rasagiline to Safinamide as an Add-On Therapy Regimen in Patients with Levodopa: A Literature Review

    Brain Sciences, Vol. 13, Núm. 2

  6. The Early Treatment Phase in Parkinson's Disease: Not a Honeymoon for All, Not a Honeymoon at All?

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 323-328

  7. ¿Qué piensan los estudiantes de Medicina sobre los trastornos neurológicos funcionales?

    Revista de neurologia, Vol. 76, Núm. 8, pp. 265-271

2022

  1. Efficacy and safety of high doses of safinamide in advanced Parkinson disease

    Parkinsonism and Related Disorders

  2. Eye-of-the-Tiger Sign with an Unexpected Pathological Diagnosis

    Movement Disorders Clinical Practice, Vol. 9, Núm. 1, pp. 98-103

  3. The silver linings of Parkinson’s disease

    npj Parkinson's Disease

2021

  1. Apomorphine: A powerful ally in parkinson's disease

    Revista de Neurologia, Vol. 72, Núm. 9, pp. 323-332

  2. Does the Country Make a Difference in Impulse Control Disorders? A Systematic Review

    Movement Disorders Clinical Practice, Vol. 8, Núm. 1, pp. 25-32

  3. High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 4, pp. 761-769

  4. Impact of SAfinamide on depressive symptoms in parkinson’s disease patients (SADness-PD Study): A multicenter retrospective study

    Brain Sciences, Vol. 11, Núm. 2, pp. 1-11

  5. Impulse Control Disorders in Parkinson's Disease: Has COVID-19 Related Lockdown Been a Trigger?

    Movement Disorders Clinical Practice, Vol. 8, Núm. 6, pp. 940-943

  6. Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1

    Neurologia, Vol. 36, Núm. 2, pp. 149-158

  7. Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2

    Neurologia, Vol. 36, Núm. 2, pp. 159-168

  8. Mutational spectrum of GNAL, THAP1 and TOR1A genes in isolated dystonia: study in a population from Spain and systematic literature review

    European Journal of Neurology, Vol. 28, Núm. 4, pp. 1188-1197